Comparison of anti HCV signal-to-cutoff ratio with HCV RNA results
dc.authorid | 0000-0002-6011-7775 | en_US |
dc.authorid | 0000-0002-5676-6983 | en_US |
dc.authorid | 0000-0003-2183-7080 | en_US |
dc.contributor.author | Avcıoğlu, Fatma | |
dc.contributor.author | Behçet, Mustafa | |
dc.contributor.author | Kalaycıoğlu, Oya | |
dc.date.accessioned | 2023-05-17T11:59:58Z | |
dc.date.available | 2023-05-17T11:59:58Z | |
dc.date.issued | 2021 | en_US |
dc.department | BAİBÜ, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü | en_US |
dc.description.abstract | Background: Anti-HCV antibody level screening is used in the diagnosis of HCV. However, a positive (S/Co > 1) result in the anti-HCV test does not always reflect true positivity. Antibody level results of S/Co ratio > 1 have to be validated through HCV RNA. In this study, we aimed to compare the signal-to-cutoff ratios of patients with positive (> 1) HCV antibody levels with the results of HCV RNA by PCR. Methods: In total, 17,021 samples were tested for anti HCV between January 2017 and December 2019. HCV antibody (anti HCV) was performed with a fully automated chemiluminescent microparticle immunoassay (CMIA, Abbot (R), Architect System). Real Time PCR test (Anatolia Geneworks HCV, Turkey) was used as nucleic acid amplification method. Results: Of the 17,021 patients, 16,706 (98.15%) tested negative and 315 (1.85%) tested positive in the anti-HCV assay. An additional HCV RNA test was requested for these 315 patients with positive anti-HCV assay results (S/Co >= 1) of which 23.81% (75/315) were positive for HCV RNA in serum, with a median (IQR): 5.43 log(10) IU/mL (4.75 - 6.01 log(10) IU/mL). Patients who tested positive for HCV RNA had significantly higher S/Co values compared to patients who tested negative (median (IQR): 13.38 (12.30 - 14.57) vs. 1.79 (1.34 - 1.79), p < 0.001). Conclusions: When S/Co ratios of patients who tested anti-HCV positive and HCV RNA positive were evaluated, it was assumed that high S/Co values were more relevant to true positivity. It was also concluded that low S/Co ratios needed to be verified through PCR. | en_US |
dc.identifier.citation | Avcioglu, F., Behcet, M., & Kalaycioglu, O. (2021). Comparison of Anti HCV Signal-to-Cutoff Ratio with HCV RNA Results. Clinical laboratory, 67(2), 376-380. | en_US |
dc.identifier.doi | 10.7754/Clin.Lab.2020.200738 | |
dc.identifier.endpage | 380 | en_US |
dc.identifier.issn | 1433-6510 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.pmid | 33616333 | en_US |
dc.identifier.scopus | 2-s2.0-85102222176 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 376 | en_US |
dc.identifier.uri | http://dx.doi.org/10.7754/Clin.Lab.2020.200738 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12491/10905 | |
dc.identifier.volume | 67 | en_US |
dc.identifier.wos | WOS:000648744300023 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Avcıoğlu, Fatma | |
dc.institutionauthor | Behçet, Mustafa | |
dc.institutionauthor | Kalaycıoğlu, Oya | |
dc.language.iso | en | en_US |
dc.publisher | Clinical Laboratory Publication | en_US |
dc.relation.ispartof | Clinical Laboratory | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Anti HCV | en_US |
dc.subject | HCV RNA | en_US |
dc.subject | Screening Test | en_US |
dc.subject | Hepatitis-C | en_US |
dc.subject | Virus | en_US |
dc.title | Comparison of anti HCV signal-to-cutoff ratio with HCV RNA results | en_US |
dc.type | Article | en_US |